Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein

Vaccine

Volumn 24, Issue 19, 2006, Pages 4102-4110

  Echeverria, Pablo Christian ^a   de Miguel, Natalia ^a   Costas, Monica ^b   Angel, Sergio Oscar ^a  

^a UB2   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Hsp90; Immunity; Toxoplasma gondii; Vaccine

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2C ANTIBODY; LI HEAT SHOCK PROTEIN 83; PROTOZOAL PROTEIN; ROP 2 PROTEIN; ROP2 83 PROTEIN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNOSTIMULATION; LEISHMANIA INFANTUM; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROVOCATION TEST; SURVIVAL RATE; TH1 CELL; TH2 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; HEAT-SHOCK PROTEINS; IMMUNITY, CELLULAR; LEISHMANIA INFANTUM; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT FUSION PROTEINS; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, SYNTHETIC;

EID: 33646469572     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.039     Document Type: Article

References (51)

1. Wells A.D., and Malkovsky M. Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. Immunol Today 21 3 (2000) 129-132
2. Multhoff G., Mizzen L., Winchester C.C., et al. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Exp Hematol 27 11 (1999) 1627-1636
3. Asea A., Kabingu E., Stevenson M.A., and Calderwood S.K. HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones 5 5 (2000) 425-431
4. Rico A.I., Girones N., Fresno M., Alonso C., and Requena J.M. The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones 7 4 (2002) 339-346
5. Aosai F., Chen M., Kang H.K., et al. Toxoplasma gondii-derived heat shock protein HSP70 functions as a B cell mitogen. Cell Stress Chaperones 7 4 (2002) 357-364
6. Suzue K., and Young R.A. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. J Immunol 156 2 (1996) 873-879
7. Huang Q., Richmond J.F., Suzue K., Eisen H.N., and Young R.A. In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4(+) T cell independent. J Exp Med 191 2 (2000) 403-408
8. Rico A.I., Del Real G., Soto M., et al. Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice. Infect Immun 66 1 (1998) 347-352
9. Rico A.I., Angel S.O., Alonso C., and Requena J.M. Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol Immunol 36 17 (1999) 1131-1139
10. Maranon C., Thomas M.C., Planelles L., and Lopez M.C. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes. Mol Immunol 38 4 (2001) 279-287
11. Qazi K.R., Wikman M., Vasconcelos N.M., Berzins K., Stahl S., and Fernandez C. Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine 23 9 (2005) 1114-1125
12. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 30 12-13 (2000) 1217-1258
13. Gazzinelli R.T., Hakim F.T., Hieny S., Shearer G.M., and Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146 1 (1991) 286-292
14. Gazzinelli R.T., Hayashi S., Wysocka M., et al. Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. J Eukaryot Microbiol 41 5 (1994) 9S
15. Khan I.A., Ely K.H., and Kasper L.H. Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. J Immunol 152 4 (1994) 1856-1860
16. Suzuki Y., Orellana M.A., Schreiber R.D., and Remington J.S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240 4851 (1988) 516-518
17. Bout D.T., Mevelec M.N., Velge-Roussel F., Dimier-Poisson I., and Lebrun M. Prospects for a human Toxoplasma vaccine. Curr Drug Targets Immune Endocr Metabol Disord 2 3 (2002) 227-234
18. Scheerlinck J.P., Casey G., McWaters P., et al. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19 28-29 (2001) 4053-4060
19. Pascual D.M., Morales R.D., Gil E.D., Muñoz L.M., López J.E., and Casanueva O.L.J. Adjuvants: present regulatory challenges. Vaccine (2005) doi:10.1016/j.vaccine.2005.01.136
20. Petersen E., Nielsen H.V., Christiansen L., and Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 16 13 (1998) 1283-1289
21. Martin V., Supanitsky A., Echeverria P.C., et al. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol 11 4 (2004) 704-710
22. Alexander J., Jebbari H., Bluethmann H., Satoskar A., and Roberts C.W. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr Top Microbiol Immunol 219 (1996) 183-195
23. Araujo F.G., Williams D.M., Grumet F.C., and Remington J.S. Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun 13 5 (1976) 1528-1530
24. Brown C.R., Hunter C.A., Estes R.G., et al. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85 3 (1995) 419-428
25. Suzuki Y., Joh K., Orellana M.A., Conley F.K., and Remington J.S. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. Immunology 74 4 (1991) 732-739
26. Fachado A., Rodriguez A., Angel S.O., et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21 13-14 (2003) 1327-1335
27. Fachado A., Rodriguez A., Molina J., et al. Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii. Infect Immun 71 9 (2003) 5407-5411
28. Blackwell J.M., Roberts C.W., and Alexander J. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol 15 6 (1993) 317-324
29. McLeod R., Skamene E., Brown C.R., Eisenhauer P.B., and Mack D.G. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J Immunol 143 9 (1989) 3031-3034
30. Liesenfeld O. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?. J Infect Dis 185 Suppl. 1 (2002) S96-S101
31. Rachinel N., Buzoni-Gatel D., Dutta C., et al. The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J Immunol 173 4 (2004) 2725-2735
32. Vercammen M., Scorza T., Huygen K., et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 68 1 (2000) 38-45
33. Nigro M., Martin V., Kaufer F., Carral L., Angel S.O., and Pszenny V. High level of expression of the Toxoplasma gondii-recombinant Rop2 protein in Escherichia coli as a soluble form for optimal use in diagnosis. Mol Biotechnol 18 3 (2001) 269-273
34. Angel S.O., Requena J.M., Soto M., Criado D., and Alonso C. During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response. Acta Trop 62 1 (1996) 45-56
35. Martin V., Arcavi M., Santillan G., et al. Detection of human Toxoplasma-specific immunoglobulins A, M, and G with a recombinant Toxoplasma gondii rop2 protein. Clin Diagn Lab Immunol 5 5 (1998) 627-631
36. Radford K.J., Higgins D.E., Pasquini S., et al. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Ther 9 21 (2002) 1455-1463
37. Martin R.M., Brady J.L., and Lew A.M. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 212 2 (1998) 187-192
38. Suzue K., Zhou X., Eisen H.N., and Young R.A. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc Natl Acad Sci USA 94 24 (1997) 13146-13151
39. Gullo C.A., and Teoh G. Heat shock proteins: to present or not, that is the question. Immunol Lett 94 1-2 (2004) 1-10
40. Binder R.J., Han D.K., and Srivastava P.K. CD91: a receptor for heat shock protein gp96. Nat Immunol 1 2 (2000) 151-155
41. Binder R.J., Harris M.L., Menoret A., and Srivastava P.K. Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells. J Immunol 165 5 (2000) 2582-2587
42. Basu S., Binder R.J., Ramalingam T., and Srivastava P.K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14 3 (2001) 303-313
43. Zheng H., Dai J., Stoilova D., and Li Z. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J Immunol 167 12 (2001) 6731-6735
44. Breloer M., Marti T., Fleischer B., and von Bonin A. Isolation of processed H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96. Eur J Immunol 28 3 (1998) 1016-1021
45. Richter K., and Buchner J. Hsp90: chaperoning signal transduction. J Cell Physiol 188 3 (2001) 281-290
46. Singh-Jasuja H., Scherer H.U., Hilf N., et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30 8 (2000) 2211-2215
47. Retzlaff C., Yamamoto Y., Hoffman P.S., Friedman H., and Klein T.W. Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun 62 12 (1994) 5689-5693
48. Galdiero M., de l'Ero G.C., and Marcatili A. Cytokine and adhesion molecule expression in human monocytes and endothelial cells stimulated with bacterial heat shock proteins. Infect Immun 65 2 (1997) 699-707
49. Palliser D., Huang Q., Hacohen N., et al. A role for Toll-like receptor 4 in dendritic cell activation and cytolytic CD8+ T cell differentiation in response to a recombinant heat shock fusion protein. J Immunol 172 5 (2004) 2885-2893
50. Yap G.S., and Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201 2 (1999) 240-247
51. Desolme B., Mevelec M.N., Buzoni-Gatel D., and Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18 23 (2000) 2512-2521